Align Technology, Inc. (NASDAQ:ALGN) – Stock analysts at Jefferies Group lifted their FY2017 EPS estimates for shares of Align Technology in a research note issued to investors on Thursday. Jefferies Group analyst B. Couillard now forecasts that the medical equipment provider will post earnings of $3.65 per share for the year, up from their previous forecast of $3.40. Jefferies Group also issued estimates for Align Technology’s Q4 2017 earnings at $0.95 EPS, Q1 2018 earnings at $0.93 EPS, Q2 2018 earnings at $1.11 EPS, Q3 2018 earnings at $1.18 EPS and Q4 2018 earnings at $1.21 EPS.

Other equities research analysts also recently issued reports about the company. Stifel Nicolaus restated a “buy” rating and set a $225.00 price objective (up from $205.00) on shares of Align Technology in a report on Thursday, October 19th. Robert W. Baird set a $208.00 price objective on Align Technology and gave the stock a “buy” rating in a report on Wednesday, October 18th. Northcoast Research restated a “buy” rating and set a $230.00 price objective (up from $200.00) on shares of Align Technology in a report on Tuesday, October 10th. Piper Jaffray Companies restated a “buy” rating and set a $176.00 price objective on shares of Align Technology in a report on Friday, July 28th. Finally, Bank of America Corporation upgraded Align Technology from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $175.00 to $193.00 in a report on Friday, July 28th. Eleven analysts have rated the stock with a buy rating, The stock currently has a consensus rating of “Buy” and a consensus price target of $219.18.

ILLEGAL ACTIVITY NOTICE: “Align Technology, Inc. (ALGN) to Post FY2017 Earnings of $3.65 Per Share, Jefferies Group Forecasts” was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/align-technology-inc-algn-to-post-fy2017-earnings-of-3-65-per-share-jefferies-group-forecasts/1694786.html.

Shares of Align Technology (NASDAQ:ALGN) opened at $249.46 on Friday. Align Technology has a twelve month low of $88.56 and a twelve month high of $254.19. The stock has a market capitalization of $20,014.76, a P/E ratio of 73.86, a price-to-earnings-growth ratio of 2.39 and a beta of 1.42.

Align Technology (NASDAQ:ALGN) last announced its earnings results on Thursday, October 26th. The medical equipment provider reported $1.01 EPS for the quarter, beating the consensus estimate of $0.82 by $0.19. The business had revenue of $385.30 million for the quarter, compared to the consensus estimate of $359.80 million. Align Technology had a return on equity of 25.60% and a net margin of 19.98%. The company’s revenue was up 38.3% on a year-over-year basis. During the same period last year, the business posted $0.63 EPS.

In other news, Director Greg J. Santora sold 7,700 shares of Align Technology stock in a transaction that occurred on Tuesday, October 31st. The stock was sold at an average price of $238.95, for a total value of $1,839,915.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CMO Raphael Pascaud sold 5,400 shares of Align Technology stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $241.88, for a total value of $1,306,152.00. Following the completion of the transaction, the chief marketing officer now owns 22,228 shares of the company’s stock, valued at approximately $5,376,508.64. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently modified their holdings of the company. Crossmark Global Holdings Inc. acquired a new position in shares of Align Technology in the 3rd quarter worth approximately $2,875,000. Oppenheimer & Co. Inc. acquired a new position in shares of Align Technology in the 2nd quarter worth approximately $1,768,000. Dynamic Technology Lab Private Ltd acquired a new position in shares of Align Technology in the 2nd quarter worth approximately $454,000. American Century Companies Inc. boosted its position in Align Technology by 2,236.0% during the 2nd quarter. American Century Companies Inc. now owns 221,009 shares of the medical equipment provider’s stock valued at $33,178,000 after purchasing an additional 211,548 shares during the period. Finally, Robeco Institutional Asset Management B.V. boosted its position in Align Technology by 17.8% during the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 90,969 shares of the medical equipment provider’s stock valued at $13,657,000 after purchasing an additional 13,753 shares during the period. Institutional investors own 81.16% of the company’s stock.

About Align Technology

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Earnings History and Estimates for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.